Protein ligands

CBS offers expertise in protein ligand design, including inhibitors and modulators, through fragment-based screening combined with structural biology and biophysics. Fragment screening enables the identification of initial binding hits, which are then characterized and optimized into potent and selective ligands.

Application: Fragment screening enables the discovery of novel ligands through de novo design as well as the optimization of existing ligands.

Description: CBS maintains its own fragment library. Fragments are typically screened using NMR spectroscopy, thermal shift assays (TSA), and/or X-ray crystallography. Identified hits are subsequently validated and prioritized through orthogonal screening methods and the screening of analogues.